default author photo

Paul Lehner

University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS

245

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Retrospective Diagnosis of SARS-CoV-2 Infection in Patients with Long COVID by Measuring Specific T Cell Mediated IL-2 Release

Number of pages: 20 Posted: 27 Oct 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University Teaching Hospital, Addenbrooke's - Department of Infectious Diseases, affiliation not provided to SSRN, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, National Institutes for Health Research (NIHR) Cambridge Biomedical Research Centre, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University NHS Hospitals Foundation Trust - Department of Infectious Diseases, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 103 (674,591)

Abstract:

Loading...

COVID, Long COVID, SARS-CoV-2, T cell assay, Interleukin-2, Interferon gamma, SARS-CoV2 antibodies/serology

2.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 59 (970,490)

Abstract:

Loading...

3.

Cigarette Smoke Preferentially Induces Full Length ACE2 Expression in Differentiated Primary Human Airway Cultures But Does Not Alter Susceptibility to SARS-CoV-2 Infection

Number of pages: 33 Posted: 06 Oct 2022
University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, affiliation not provided to SSRN, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Department of Medicine
Downloads 53 (1,031,043)

Abstract:

Loading...

SARS-CoV-2, primary human bronchial epithelial cells, ACE2, air-liquid interface, cigarette smoke extract

4.

Human Cytomegalovirus pUS22: A Novel Transcriptional Inhibitor That Represses Cellular Necroptosis

Number of pages: 35 Posted: 12 Nov 2025
University of Cambridge, University of Cambridge, Cardiff University, University of Cambridge, University of Cambridge - Cambridge Institute for Medical Research, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cardiff University, University of Cambridge - Cambridge Institute for Medical Research and Independent
Downloads 30 (1,318,317)

Abstract:

Loading...

Human cytomegalovirus, Proteomics, systems virology, necroptosis, cell death, Host-pathogen interaction, transcriptional regulation